Outside Consultant Will Evaluate FDA's Postmarketing Studies Practices

The FDA has awarded a $1.09 million contract for an evaluation of the agency's process of establishing postmarketing, or phase IV, studies. The consulting firm of Booz Allen Hamilton will conduct the 1-year evaluation and make recommendations to the agency for improving and standardizing the process.

Related Content:

Oncology NEWS International Vol 15 No 6

Triple-Negative Cancers More Common in Young Black Pts

Artists Turn Flowers & Curves Into 'Forms' and 'Figures'

Study to Examine Outcomes Disparities in Pediatric ALL